Altimmune, Inc. (ALT)
3.88
-1.15
(-22.86%)
USD |
NASDAQ |
Dec 19, 16:00
3.92
+0.04
(+1.03%)
After-Hours: 16:43
Altimmune Shareholders Equity (Annual): 123.51M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Viking Therapeutics, Inc. | 880.28M |
| Eli Lilly & Co. | 14.19B |
| Pfizer Inc. | 88.20B |
| Terns Pharmaceuticals, Inc. | 345.87M |
| Rhythm Pharmaceuticals, Inc. | 21.73M |